Raniah Al-Jaizani M.Sc Lecturer, Clinical Pharmacy Dept.

Slides:



Advertisements
Similar presentations
A lady with vomiting. A 23-year-old female student presents to her GP 5 days after returning from a ski holiday. She developed what she thought was a.
Advertisements

Selected Clinical Calculations
Clinical Pharmacokinetics Review Keith Christensen, Pharm D, BCPS Assistant Professor of Pharmacy Practice Pulmonary & Critical Care Medicine Creighton.
7. Anti-TB regimen in special situations of liver disease, renal impairment, and pregnancy.
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Clinical Case 3. A 14 year old girl was brought to her GP’s office, complaining of: – weight loss, – dry mouth, – lethargy, – easy fatigability – and.
Pharmacokinetics Questions
Dosage Regimen Design for Patients with Renal Insufficiency Pharmacy 732 Winter, 2001.
Fluids and Electrolytes
Introduction to Prescribing - Part 2 3 rd year Medical Students.
By: Janel Canty RNS (Osborn, 2010). Objectives To understand Hyponatremia To be able to recognize hyponatremia in a clinical setting Be able to apply.
Fluids and Electrolytes
CASE 1 TDM Case Presentation By : Group B
Rapivab™ - peramivir injection
Practical Prescribing Session Berny Baretto (Antibiotic Pharmacist) 30 th August 2012.
CHILDHOOD SLE IN THE 21 ST CENTURY THE STATE OF THE ART How do we get the best possible outcome Thomas J. A. Lehman MD Chief, Division of Pediatric rheumatology.
Diabetic Ketoacidosis DKA)
Inpatient Pharmacy Vivian Sinkaset, Pharm.D., BCPS Miramar Science Club Guest Speaker April 28, 2010.
Unit 7 Treatment of TB: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.
E RRORS IN T RANSFER O RDERS Keith Lau, M.D. Department of Pediatrics McMaster University October 15, 2009.
Infectious Disease: Update on FDA Notices in 2007 Valerie A. Bush, PharmD Clinical Pharmacy Specialist- Internal Medicine Greenville Hospital System University.
 At the end of the lecture, students should :  Describe briefly common types of meningitis  Describe the principles of treatment  List the name of.
Aminoglycoside-Induced Acute Tubular Necrosis PHCL 442 Lab Discussion 2 Raniah Al-Jaizani M.Sc.
Challenges in the evaluation of hyponatremia Meera Ladwa (SpR Endocrine&Diabetes) Dr Steve Hyer.
NYU Medical Grand Rounds Clinical Vignette Glenn Dym, MD PGY3 Tuesday, April 24 th, 2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Background  Obesity is defined as a body mass index (BMI) ≥30 kg/m 2  33 states have a prevalence of obesity 25% or greater  Evidence illustrates that.
Hypoglycemia & Hyperglycemia Dave Joffe, BSPharm, CDE, FACA Part 4.
VCU DEATH AND COMPLICATIONS CONFERENCE
Hospital Acquired Pneumonia(HAP): is defined as a pneumonia which occurs after 48 hours of admission to hospital. Hospital Acquired Pneumonia(HAP): is.
Therapeutic Drug Monitoring (TDM) Sticker Project A New Method for Documenting Times of Medication Doses and Drug Levels.
HTN Cases Pharmacotherapy - 1. Case 1 TJ is a 45-year-old woman with a history of type 2 diabetes mellitus treated with glyburide 5 mg/ day. She.
Diabetic Ketoacidosis DKA PHCL 442 Lab Discussion 6 Raniah Al-Jaizani M.Sc.
Clinical Pharmacokinetics of Aminoglycosides
Pharmacokinetics of Vancomycin in Adult Oncology Patients Hadeel Al-Kofide MS.c; Iman Zaghloul PhD; and Lamya Al-Naim PharmD Department of Clinical Pharmacy,
Clinical Pharmacokinetic Equations and Calculations
Acute Medicine M5 Seminar (Hypoglycaemia) Yeo Xinying 19 Jan 2005.
Case 9 Amikacin in an elderly CKD patient Block 9 : Divine Ramos, Remonte, Reyes, Rivera A, Rivera K, Rivera M, Rogelio, Sagayaga, Santiago, See, Siy,
CLINICAL USE OF DIURETICS. PATHOGENESIS AND TREATMENT OF REFRACTORY EDEMA Determinants of diuretic response - site of action, antinatriuretic forces,
C-1 Safety Results S. aureus Bacteremia and Endocarditis Study Gloria Vigliani, M.D. Vice President, Medical Strategy Cubist Pharmaceuticals.
Dosage Calculations Mark Wagner, PharmD Kirollos Hanna, PharmD, BCPS PGY-2 Oncology Resident St. Luke’s Mountain States Tumor Institute March 5 th, 2016.
Pharmacokinetic Questions
Therapeutics 3 Tutoring Exam 4 February 27 th, 2016 Lisa Hayes
“Monitoring Systemic Lupus Erythematosus” Andres Quiceno, MD Presbyterian Hospital of Dallas.
HAP and VAP Guidelines Update
Endocarditis Tutoring
Pneumococcal Vaccination Small group cases:Facilitator’s Guide
Electrolytes Tutoring (Part 2): calcium, Phosphate, Potassium, and Magnesium By Alaina darby.
Mini Lecture: IV Fluids
Nephrotoxicity Poisonous effect of some substances both toxic chemicals and medication. Nephrotoxins are chemicals displaying nephrotoxicity.
Allie punke pharmcokinetics Allie punke
Clinical Pharmacokinetics of VANCOMYCIN
The aminoglycoside antibiotics
Miscellaneous Antibiotics
Monoclonal Antibodies
More Antibiotics Tutoring
Therapeutic Drug Monitoring of Levofloxacin
Drugs used in Meningitis Prof. Azza ELMedany
Electrolytes Tutoring (Part 2): calcium, Phosphate, Potassium, and Magnesium By Alaina darby.
Pharmacokinetics: immunosuppressive drugs
Assist. Prof. Dr. Kadhim Ali Kadhim Ph.D, in Clinical Pharmacy
Renal Pharmacy Group Beginners Lectures 2018
Clinical Pharmacokinetics
Pharmcokinetics Allie punke.
considering further dose(s)
Allie Punke Pharmacokinetics Allie Punke
Oral Anticoagulant Reversal Agents
Gentamicin – principles of use and monitoring
Aspirin & NSAID.
Presentation transcript:

Raniah Al-Jaizani M.Sc Lecturer, Clinical Pharmacy Dept. Dosing of drugs in Renal failure Raniah Al-Jaizani M.Sc Lecturer, Clinical Pharmacy Dept.

Dosing of drugs in Renal failure CASE 1 G.G., a 31 y.o, woman IBW 70 kg with 3 yr hx of SLE, present to ER with 3 days hx of fatigue, weakness, nausea, and fever. Laboratory value: Na= 142 mEq/L (135-144) Srcr= 3.4 mg/dl (0.6-1.2) BUN= 38 mg/dl (7-20) Two weeks into her hospital course, G.G’s condition worse and she develops sings of sepsis. Pseudomonas aeruginosa is cultured from her urine. Therapy with ceftazidime (1g every 24 hr) was initiated. G.G’s medical team decide that the addition of an aminoglycoside is now necessary. How should the gentamicin be dosed in G.G?

Dosing of drugs in Renal failure Case 1 (Answer) Normal dose in sever life-theratening infections: 2-2.5 mg/ kg/dose 90-97 % excreted renally Clcr= 26.7 ml/min Clcr 20-40 ml/min: 100% of normal dose administered every 24 hr So, G.G dose of gentamicin 140 q 24 hr Peak and trough level should be monitored

Dosing of drugs in Renal failure CASE 2 D.M, a 28 y.o, 50 kg man with AIDS present with sever herpetic infection requiring I.V acyclovir. Due to other complication associated with his HIV virus, D.M has developed renal insufficiency during his hospital course. His Srcr= 4.5 mg/dl (0.6-1.2) How should acyclovair be dosed in D.M?

Dosing of drugs in Renal failure Case 2 (Answer) Normal dose=10 mg/kg intravenously over 1 hour, every 8 hours 76-82 % excreted renally Clcr= 17.2 ml/min Clcr 10-25 ml/min: 5-10 mg/kg/dose administered every 24 hr So, D.M acyclovair I.V dose 500 mg I.V infused over 1 hour q 24 hours

Dosing of drugs in Renal failure CASE 3 Huda is medical intern in KKUH call drug information center asking you some question about vancomycin. What is the normal dose of vancomycin? Should vancomycin dose adjusted in renal failure patients? K.A, is 55 y.o female, 80 kg, with MRSA and vancomycin should be initiated what is the dose of vancomycin if her Srcr= 2 mg/dl (0.6-1.2)

Dosing of drugs in Renal failure Case 3 (Answer) Normal dose= 1 g every 12 hr Yes, 80-90 % excreted renally Clcr= 40 ml/min Clcr 40-60 ml/min: start with 1g or 10-15 mg/kg/dose every 24 hr So, K.A dose of vancomycin 1 g I.V infused over 2 hours q 24 hr Peak and trough level should be monitored